Publicité
Publicité

STIM

STIM logo

Neuronetics, Inc. Common Stock

2.06
USD
Sponsorisé
+0.10
+5.36%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

2.12

+0.05
+2.62%

STIM Rapports sur les bénéfices

Ratio de surprise positive

STIM a dépassé 17 des 30 dernières estimations.

57%

Prochain rapport

Date du prochain rapport
02 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$41.48M
/
-$0.10
Variation implicite de Q3 25 (Revenue/ EPS)
+11.22%
/
-23.08%
Variation implicite de Q4 24 (Revenue/ EPS)
+84.41%
/
-69.70%

Neuronetics, Inc. Common Stock earnings per share and revenue

On 04 nov. 2025, STIM reported earnings of -0.13 USD per share (EPS) for Q3 25, missing the estimate of -0.12 USD, resulting in a -0.62% surprise. Revenue reached 37.30 million, compared to an expected 38.60 million, with a -3.38% difference. The market reacted with a +3.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analystes forecast an EPS of -0.10 USD, with revenue projected to reach 41.48 million USD, implying an baisse of -23.08% EPS, and hausse of 11.22% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 janv. 2026 Pour Q2 26
Estimation
-$0.10
Actuel
$0.00
Surprise
+100.00%
FAQ
For Q3 2025, Neuronetics, Inc. Common Stock reported EPS of -$0.13, missing estimates by -0.62%, and revenue of $37.30M, -3.38% below expectations.
The stock price moved up 3.61%, changed from $2.77 before the earnings release to $2.87 the day after.
The next earning report is scheduled for 02 mars 2026.
Based on 5 analystes, Neuronetics, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $41.48M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité